Corcept’s Voluntary Central Distribution Helps Korlym Evade REMS

By Shirley Haley / Email the Author / “The Pink Sheet” DAILY Feb. 17, 2012
Word Count: 592 / Article # 14120217006

Executive Summary

FDA required no REMS, though Korlym (mifepristone), also known as RU-486, will carry a boxed warning that the therapy for Cushing’s syndrome will terminate pregnancy; Corcept has set up distribution through a central pharmacy.

Purchase this Article

$35.00 Buy Now

For $35.00, purchase this 592-word article and receive immediate online access. 100% Satisfaction Guarantee.

View a complete sample article »

Already a Subscriber?

Log in for complete access.

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.

+ Show All | – Hide All

There are no current related articles

Offers & Events

Topics Covered in this Article

Click a keyword for related articles.
General Topics
rare disorders
Subjects
Regulatory
Product Approvals
Drugs
Industries
Biopharmaceuticals
Therapeutic Area(s) of Focus
Metabolic Disorders
Diabetes
Type 2 Diabetes
Companies
Corcept Therapeutics Inc.
Novartis AG

Log In

Email Address

Password

Remember Me

Forgot your password?

Don’t Have an Account?

If your employer has a site license, create your account to begin using it. Simply click ‘Create An Account’ button below to register now.

Otherwise, please explore our free content subscriptions.

Create an account

Enter the email address associated with your account and a temporary password will be sent to you.

Email Address

Need help? Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com

Email Article

* Required field

* To:

For multiple recipients, separate email addresses with a semi-colon.

* Your Name:

* Your Email:

Subject: Corcept’s Voluntary Central Distribution Helps Korlym Evade REMS

* Add a personalized message to your email:

Please Note: Only individuals with subscriptions to “The Pink Sheet” DAILY will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.

or Cancel